Bi Pharma

Bi Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Bi Pharma est un prestataire de l'industrie pharmaceutique proposant des services opérationnels uniques : 1. BI Pharma Distribution (depuis 2016) : votre solution logistique. Nous gérons la distribution et la promotion avec notre partenaire Sophar de vos produits de santé sur l'Outremer et la métropole. 2 . BI Pharma RH (depuis 2017) : vous accompagner dans l'externalisation de vos postes siège ou terrain pour des missions de moyenne durée pour des profils nécessitant une expérience ou un profil pas si simple à trouver (ex : vacancy, phase pilote/test, ...). Notre partenariat avec le cabinet CDG Conseil nous permet d'identifier le bon candidat dans des délais rapides. 3. BI Pharma Intelligence Economique (depuis 2018) : nous proposons des missions d'intelligence économique spécialisées santé grâce à notre logiciel propriétaire e-perion et notre équipe d'analystes : cartographie 360° (société, environnement, partenaire ...), stratégie e-santé (veille, e-reputation, cyber-sécurité ...). N'hésitez pas à nous contacter pour plus d'informations. contact@bipharma.net

Company Details

Employees
27
Founded
-
Address
3 Rue Des Batignolles, Paris,île-De-France 75017,france
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Paris, Île-de-France
Looking for a particular Bi Pharma employee's phone or email?

Bi Pharma Questions

News

Egypt: Alex Pharma’s net profits increase 5.3% YoY in Q1 FY2025/26 - ZAWYA

Egypt: Alex Pharma’s net profits increase 5.3% YoY in Q1 FY2025/26 ZAWYA

Sun Pharma net profit falls on US antitrust settlement, drug impairment costs - Mint

Sun Pharma net profit falls on US antitrust settlement, drug impairment costs Mint

Destocking drags down Piramal Pharma Q1 performance, reports net loss of ₹82 cr - ETPharma.com

Destocking drags down Piramal Pharma Q1 performance, reports net loss of ₹82 cr ETPharma.com

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1 - Medical Dialogues

Aurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1 Medical Dialogues

Indies Pharma Net Profits Dip To $7.2 Million - RJR News

Indies Pharma Net Profits Dip To $7.2 Million RJR News

Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25 - ZAWYA

Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25 ZAWYA

Mankind Pharma net drops 17.4% YoY to Rs 445 crore in Q1FY26 - Moneycontrol

Mankind Pharma net drops 17.4% YoY to Rs 445 crore in Q1FY26 Moneycontrol

Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9% - Business Standard

Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9% Business Standard

Ajanta Pharma Q1 Net Profit Rises 4% To Rs 255 Crore - NDTV Profit

Ajanta Pharma Q1 Net Profit Rises 4% To Rs 255 Crore NDTV Profit

Torrent Pharma Q1 Results: Net profit jumps 20% to Rs 548 crore - The Economic Times

Torrent Pharma Q1 Results: Net profit jumps 20% to Rs 548 crore The Economic Times

Fredun Pharma Q1 Results: Net up 64% on robust demand, product diversification - BusinessLine

Fredun Pharma Q1 Results: Net up 64% on robust demand, product diversification BusinessLine

Sun Pharma Q4 revenue nears ₹13000 cr, weak US sales drags down net profit - ETPharma.com

Sun Pharma Q4 revenue nears ₹13000 cr, weak US sales drags down net profit ETPharma.com

Ajanta Pharma Net Profit Rises 4% to ₹255 Cr in Jun Qtr - outlookbusiness.com

Ajanta Pharma Net Profit Rises 4% to ₹255 Cr in Jun Qtr outlookbusiness.com

Sun Pharma Q1 Results: Net profit declines 20% to ₹2,279 crore; revenue up 9% - Mint

Sun Pharma Q1 Results: Net profit declines 20% to ₹2,279 crore; revenue up 9% Mint

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 - Medical Dialogues

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1 Medical Dialogues

Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend - Moneycontrol

Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend Moneycontrol

Sun Pharma net profit jumps 15% to Rs 2,903 crore in Q3FY25 - The Economic Times

Sun Pharma net profit jumps 15% to Rs 2,903 crore in Q3FY25 The Economic Times

Ajanta Pharma net profit rises 4% to ₹255 cr in June qtr - BusinessLine

Ajanta Pharma net profit rises 4% to ₹255 cr in June qtr BusinessLine

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8% - Business Standard

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8% Business Standard

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3 - Medical Dialogues

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3 Medical Dialogues

Mankind Pharma drops 6% after net profit declines in Q3 - Moneycontrol

Mankind Pharma drops 6% after net profit declines in Q3 Moneycontrol

Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25 - The Economic Times

Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25 The Economic Times

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues - Moneycontrol

Q4 Results Highlights: Sun Pharma earning call -US contributes 31.4% of Sun Pharma revenues Moneycontrol

Piramal Pharma Q4 net profit jumps 52% to ₹154 crore; revenue up 8%, dividend declared - CNBC TV18

Piramal Pharma Q4 net profit jumps 52% to ₹154 crore; revenue up 8%, dividend declared CNBC TV18

Pharma’s path to Net Zero: Targeting Scope 3 emissions - Pharmaceutical Technology

Pharma’s path to Net Zero: Targeting Scope 3 emissions Pharmaceutical Technology

Aurobindo Pharma Q2 net profit rises 9% - Times of India

Aurobindo Pharma Q2 net profit rises 9% Times of India

Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2 - Medical Dialogues

Natco Pharma net profit jumps 83 percent to Rs 676 crore in Q2 Medical Dialogues

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog - The Hill

Top 5 largest US pharma firms’ net earnings topped $81.9 billion last year: watchdog The Hill

Seven pharma CEOs announce new joint action to accelerate net zero healthcare - AstraZeneca

Seven pharma CEOs announce new joint action to accelerate net zero healthcare AstraZeneca

How COVID-19 Vaccines Changed Pharma Company Profits - Statista

How COVID-19 Vaccines Changed Pharma Company Profits Statista

Hyphens Pharma net profit grows to $10.76m in 2024 - Singapore Business Review

Hyphens Pharma net profit grows to $10.76m in 2024 Singapore Business Review

Hengrui Pharma's net profit increased by nearly 30% in the first half of the year, with innovative drug revenue reaching 7.57 billion yuan. - 富途牛牛

Hengrui Pharma's net profit increased by nearly 30% in the first half of the year, with innovative drug revenue reaching 7.57 billion yuan. 富途牛牛

BioSpace Looks at the Top 8 Biopharma Companies by Net Income - BioSpace

BioSpace Looks at the Top 8 Biopharma Companies by Net Income BioSpace

Top 10 pharma companies in India by market cap [2025] - Forbes India

Top 10 pharma companies in India by market cap [2025] Forbes India

Sun Pharma net up 16.5% at ₹2,524 crore on robust sales - Mint

Sun Pharma net up 16.5% at ₹2,524 crore on robust sales Mint

Senores Pharma reports ₹21 crore net profit in Q1 FY26 - ETPharma.com

Senores Pharma reports ₹21 crore net profit in Q1 FY26 ETPharma.com

Torrent Pharma Q1 Results: Net profits grow 20% to ₹548 cr - BusinessLine

Torrent Pharma Q1 Results: Net profits grow 20% to ₹548 cr BusinessLine

Torrent Pharma Q2FY25 results: Net profit rises 17%, misses estimates - Business Standard

Torrent Pharma Q2FY25 results: Net profit rises 17%, misses estimates Business Standard

Aurobindo Pharma net soars 80% in Q4 on higher revenue from formulations, flat API sales - The Hindu

Aurobindo Pharma net soars 80% in Q4 on higher revenue from formulations, flat API sales The Hindu

Strides Pharma Science Q2 Results: Firm posts net profit of Rs 93.66 crore - The Economic Times

Strides Pharma Science Q2 Results: Firm posts net profit of Rs 93.66 crore The Economic Times

Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y - Moneycontrol

Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y Moneycontrol

Natco Pharma net profit rises 59% in June quarter to ₹669 crore - The Hindu

Natco Pharma net profit rises 59% in June quarter to ₹669 crore The Hindu

Mayne Pharma’s net losses more than double - AFR

Mayne Pharma’s net losses more than double AFR

Piramal Pharma net loss narrows at Rs 88.64 crore in Q1 - Medical Dialogues

Piramal Pharma net loss narrows at Rs 88.64 crore in Q1 Medical Dialogues

Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here - Business Standard

Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here Business Standard

Sun Pharma Q1 Results: Net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY - Mint

Sun Pharma Q1 Results: Net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY Mint

Piramal Pharma posts Rs 4 crore net profit in Q3FY25 - The Economic Times

Piramal Pharma posts Rs 4 crore net profit in Q3FY25 The Economic Times

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 - Via Ritzau

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 Via Ritzau

Strides Pharma Q2 results: Net profit at Rs 93.7 cr, revenue up 20% - Business Standard

Strides Pharma Q2 results: Net profit at Rs 93.7 cr, revenue up 20% Business Standard

Gland Pharma Q3 result: Net profit rises 7% to Rs 205 cr as expenses drop - Business Standard

Gland Pharma Q3 result: Net profit rises 7% to Rs 205 cr as expenses drop Business Standard

OneSource Specialty Pharma reports consolidated net profit of Rs 98.50 crore in the March 2025 quarter - Business Standard

OneSource Specialty Pharma reports consolidated net profit of Rs 98.50 crore in the March 2025 quarter Business Standard

Sun Pharma net profit rises 40% to Rs 2,836 crore - The New Indian Express

Sun Pharma net profit rises 40% to Rs 2,836 crore The New Indian Express

Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared - Moneycontrol

Sun Pharma Q3 net profit rises 15% to Rs 2,903.4 crore, meets estimate; Rs 10.5 dividend declared Moneycontrol

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details - Business Standard

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details Business Standard

Mankind Pharma net profit rockets 65% in Q4, board okays plan to raise ₹7,500 crore - CNBC TV18

Mankind Pharma net profit rockets 65% in Q4, board okays plan to raise ₹7,500 crore CNBC TV18

Sun Pharma Q1 net profit drops 20% to Rs 2,279 crore due to exceptional charge; revenue up 9.5% - Moneycontrol

Sun Pharma Q1 net profit drops 20% to Rs 2,279 crore due to exceptional charge; revenue up 9.5% Moneycontrol

Torrent Pharma Q2 Results | Net profit up 17%, revenue grows 9% - CNBC TV18

Torrent Pharma Q2 Results | Net profit up 17%, revenue grows 9% CNBC TV18

Mankind Pharma Q1 Updates: Net profit down ~18% - India Infoline

Mankind Pharma Q1 Updates: Net profit down ~18% India Infoline

Suven Pharma Q2 Results: Net profit rises 3% to Rs 82 crore - The Economic Times

Suven Pharma Q2 Results: Net profit rises 3% to Rs 82 crore The Economic Times

Piramal Pharma Q1FY25 results: Net loss narrows at Rs 88.64 crore - Business Standard

Piramal Pharma Q1FY25 results: Net loss narrows at Rs 88.64 crore Business Standard

Natco Pharma's net profit rises 31.2% to Rs 420.3 cr in June quarter - Business Standard

Natco Pharma's net profit rises 31.2% to Rs 420.3 cr in June quarter Business Standard

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10% - Business Standard

Sun Pharma Q4 results: Net profit rises 34% to Rs 2,655 cr, revenue up 10% Business Standard

Glenmark Pharma reports net loss of Rs 331 cr in Q3 FY24 - Business Standard

Glenmark Pharma reports net loss of Rs 331 cr in Q3 FY24 Business Standard

Piramal Pharma Q2FY25 results: Net profit jumps over 4-fold to Rs 23 crore - Business Standard

Piramal Pharma Q2FY25 results: Net profit jumps over 4-fold to Rs 23 crore Business Standard

Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crore - The Economic Times

Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crore The Economic Times

Why did investors dump Marksans Pharma shares post Q4 results? Know here - Business Standard

Why did investors dump Marksans Pharma shares post Q4 results? Know here Business Standard

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4% - The Economic Times

Alembic Pharma Q3 Results: Company posts 23% YoY decline in net profit at Rs 138 crore, revenue up 4% The Economic Times

Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore - CNBC TV18

Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore CNBC TV18

Sun Pharma net profit doubles in Q4 - The New Indian Express

Sun Pharma net profit doubles in Q4 The New Indian Express

Mankind Pharma Q2 results: Net profit rises to Rs 653 cr on higher demand - Business Standard

Mankind Pharma Q2 results: Net profit rises to Rs 653 cr on higher demand Business Standard

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company - financialexpress.com

Meet Juneja Brothers: How they built Rs 95,876 crore Mankind Pharma, India’s fourth largest pharma company financialexpress.com

Natco Pharma net dips 68% in Q2 - Telangana Today

Natco Pharma net dips 68% in Q2 Telangana Today

Q1 Results Highlights: Aurobindo Pharma net profit falls 10.2% YoY to ₹825 crore; Godfrey Phillips to issue 2:1 bonus shares - Upstox

Q1 Results Highlights: Aurobindo Pharma net profit falls 10.2% YoY to ₹825 crore; Godfrey Phillips to issue 2:1 bonus shares Upstox

Torrent Pharma net zooms 3-fold to Rs 568 cr - BusinessLine

Torrent Pharma net zooms 3-fold to Rs 568 cr BusinessLine

Orchid Pharma net loss narrows to Rs 53.9 crore - Business Standard

Orchid Pharma net loss narrows to Rs 53.9 crore Business Standard

Top Bi Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant